ANZCTR12622001205729

Addressing smoking in patients following discharge from Intensive Care

A brief counselling intervention addressing smoking cessation: a randomized controlled trial in Intensive Care patients
Sir Charles Gairdner and Osborne Park Hospital Group·Not Applicable·Australian New Zealand Clinical Trials RegistryNot yet recruiting
Study focus
Disease/Condition
Smoking
Study type
Interventional
Sponsor & location
Primary sponsor
Sir Charles Gairdner and Osborne Park Hospital Group
Funder
Sir Charles Gairdner Hospital
Location
Australia
Timeline & enrollment
Phase
Not Applicable
Start date
Sep 12, 2022
End date
N/A
Primary outcome

Self referral to QUIT program assessed by follow-up phone call

Summary

Despite a dramatic decline in tobacco smoking prevalence, current smoking rates have plateaued and smoking remains the leading cause of preventable diseases and death in Australia. Smoking rates in ICU patients are higher than the general population, offering an opportunity for intervention, especially as there is good evidence that many smokers do consider cessation following an ICU admission. Thus surviving an ICU admission potentially provides a unique opportunity to promote long-term smoking cessation. Whilst smoking cessation interventions have been evaluated in hospital settings, the optimal intervention remains unclear and no studies looking at combination nicotine replacement therapy (NRT) and counselling have been performed specifically in ICU survivors. Our goal is to conduct a randomized controlled trial comparing standard care (ad hoc advice to patients and NRT) to a formal brief counselling intervention in addition to protocolized NRT. The aim is to improve smoking cessation rates in ICU survivors and thus improve their morbidity and mortality.

ICD-10 classifications
Tobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco : harmful useDrug use
Data source
Registry
Australian New Zealand Clinical Trials Registry
Trial ID
ANZCTR12622001205729
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for ANZCTR12622001205729 through Pure Global AI's free database. This Not Applicable trial is sponsored by Sir Charles Gairdner and Osborne Park Hospital Group and is currently Not yet recruiting. The study focuses on Smoking.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Australian New Zealand Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.